Unibest
← Back to patent-cliff list

CAS 52523-35-0

N-(trimethylsilyl)-4-((trimethylsilyl)oxy)-1,3,5-triazin-2-amine

Codes: DECI-010, AZAC-006

Application context (from source-drug indications)

Allergic reactionDecitabineCycloplegiaDecitabineHypotensionDecitabineAcute myeloid leukaemiaDecitabineMyelodysplastic syndromeDecitabineDiffuse large B-cell lymphomaDecitabine幼年型粒单核细胞白血病AzacitidineAcute myeloid leukaemiaAzacitidineMyelodysplastic syndromeAzacitidineChronic myeloid leukaemiaAzacitidineChronic myelomonocytic leukaemiaAzacitidine脑性瘫痪Azacitidine

Source drugs (routes using this intermediate)

DrugTierExpiry
DecitabineTier C — Watch / trade-
AzacitidineTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

DecitabineOptimised routesteps: 2total yield: /

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.